| Date | Time | Source | Headline | Symbol | Company |
| 03/04/2011 | 8:30AM | Business Wire | U.S. FDA Removes Warning about Potential Liver Injury from Boxed Warning of Prescribing Information for Gilead's Letairis | NASDAQ:GILD | Gilead Sciences Inc |
| 03/03/2011 | 7:06PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 03/01/2011 | 2:33PM | Dow Jones News | CORRECT: Pharmacies Turn Tamiflu Pills To Liquid | NASDAQ:GILD | Gilead Sciences Inc |
| 03/01/2011 | 1:45PM | Dow Jones News | 2nd UPDATE: Pharmacies Turn Tamiflu Pills To Liquid | NASDAQ:GILD | Gilead Sciences Inc |
| 03/01/2011 | 11:57AM | Dow Jones News | UPDATE: Pharmacies Turn Tamiflu Pills To Liquid Amid Shortage | NASDAQ:GILD | Gilead Sciences Inc |
| 02/28/2011 | 7:08PM | Dow Jones News | Gilead: FDA Reviewed, Found No Problems At San Dimas, Calif, Site | NASDAQ:GILD | Gilead Sciences Inc |
| 02/28/2011 | 4:42PM | Edgar (US Regulatory) | Annual Report (10-K) | NASDAQ:GILD | Gilead Sciences Inc |
| 02/28/2011 | 4:30PM | Business Wire | Gilead Sciences to Present at the Cowen & Company 31st Annual Health Care Conference on Monday, March 7 | NASDAQ:GILD | Gilead Sciences Inc |
| 02/25/2011 | 2:32PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:GILD | Gilead Sciences Inc |
| 02/25/2011 | 10:28AM | Edgar (US Regulatory) | Confidential Treatment Order (CT ORDER) | NASDAQ:GILD | Gilead Sciences Inc |
| 02/24/2011 | 12:01PM | Edgar (US Regulatory) | Confidential Treatment Order (CT ORDER) | NASDAQ:GILD | Gilead Sciences Inc |
| 02/23/2011 | 4:30PM | Business Wire | Gilead Sciences to Present at Two Upcoming Investor Conferences | NASDAQ:GILD | Gilead Sciences Inc |
| 02/22/2011 | 8:30AM | Business Wire | Gilead Sciences to Acquire Calistoga Pharmaceuticals for $375 Million | NASDAQ:GILD | Gilead Sciences Inc |
| 02/18/2011 | 4:52PM | Dow Jones News | UPDATE: Obama's Chief Of Staff Made $15.4 Million In Last Few Years At JP Morgan | NASDAQ:GILD | Gilead Sciences Inc |
| 02/16/2011 | 5:48PM | Dow Jones News | UPDATE: Biotech Investors Shift Focus After Genzyme Deal | NASDAQ:GILD | Gilead Sciences Inc |
| 02/16/2011 | 2:49PM | Dow Jones News | With Genzyme Deal Official, Biotech Investors Shift Focus | NASDAQ:GILD | Gilead Sciences Inc |
| 02/14/2011 | 5:44PM | Edgar (US Regulatory) | Statement of Ownership (SC 13G) | NASDAQ:GILD | Gilead Sciences Inc |
| 02/10/2011 | 4:05PM | Business Wire | Gilead Sciences Refiles New Drug Application with the FDA for Single-Tablet Regimen of Truvada® and TMC278 | NASDAQ:GILD | Gilead Sciences Inc |
| 02/07/2011 | 5:00PM | Business Wire | Gilead Sciences Announces Notification of ANDA Filing for Tamiflu® | NASDAQ:GILD | Gilead Sciences Inc |
| 02/07/2011 | 2:40PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:GILD | Gilead Sciences Inc |
| 02/04/2011 | 2:44PM | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NASDAQ:GILD | Gilead Sciences Inc |
| 02/03/2011 | 7:45PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 02/03/2011 | 8:05AM | Marketwired | Opinions on Gilead Sciences Inc. and GlaxoSmithKline plc -- A Look at R&D in the Health Industry | NASDAQ:GILD | Gilead Sciences Inc |
| 02/01/2011 | 8:25PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 01/31/2011 | 5:09PM | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (S-8) | NASDAQ:GILD | Gilead Sciences Inc |
| 01/28/2011 | 9:31PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 01/28/2011 | 1:12PM | Dow Jones News | CDC: Anti-HIV Drug Must Be Prescribed Cautiously To Be Effective | NASDAQ:GILD | Gilead Sciences Inc |
| 01/28/2011 | 9:31AM | PR Newswire (US) | Critical Alerts for Pepsico, Johnson & Johnson, Gilead, Franklin Resources, and Jabil Circuit Released by Seven Summits Research | NASDAQ:GILD | Gilead Sciences Inc |
| 01/25/2011 | 6:41PM | Dow Jones News | 2nd UPDATE: Gilead 4Q Profit Slides 22%, Reports Pipeline Delay | NASDAQ:GILD | Gilead Sciences Inc |
| 01/25/2011 | 6:03PM | Dow Jones News | UPDATE: Gilead 4Q Profit Slides 22%, Reports Pipeline Delay | NASDAQ:GILD | Gilead Sciences Inc |